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INTRODUCTION 
Ion-exchange can be defined as an electrostatic 
interaction of ions between ions in solution and ion-
exchange resins without significant change in the 
structure and properties of the resins1.The ionic 
interactions are strongly dependent on the pH and the 
competing ions in the reaction medium. If the medium 
has many ionic species, it may decrease the electrostatic 
interaction between the resin and the ionic drug due to 
shielding and competitive binding effect. However, the 
interaction can be exploited in oral drug delivery since 
the resin can carry the drug and release it in the 
gastrointestinal (GI) tract due to the pH change or the 
presence of competing ions2. The ion-exchange resins 
can be synthesized or purchased depending on their 
applications. Generally, ion-exchange resins for ion-
exchange chromatography and deionization of water are 
suitable ones for the purpose of drug delivery systems. 
Many studies have shown that ion-exchange resins can 
have a good role as drug delivery systems 3, 4, 5, 6. 
First of all, in order to be loaded in the ion-exchange 
resin, a drug needs to have charged groups. Generally, 
the loading is accomplished using two well-known 
methods. The one is a batch method, and the other is a 
column method 7, 8.  In the batch method, a specific 
amount of resin is added to a drug solution and mixed 
until equilibrium is obtained. In the column method, a 
concentrated drug solution is passed through a resin-
packed column until the effluent concentration is the 
same as the eluent concentration. 
For the efficient drug loading, it is important to know the 
time it takes to reach equilibrium and how much drug 
will be loaded into the resin, which depends on resin-
type and loading method. The time to reach equilibrium 
and drug loading are dependent on many variables, such 
as the molecular weight and charge intensity of both the 
drug and resin, degree of cross linking and particle size 
of the resin, nature of the solvent and mixing conditions. 
If the molecules diffusing into ion-exchange particles are 
large or if the polymers in the resin are highly cross 
linked, it will take more time to reach the equilibrium 
condition. Particle size is another important factor, which 
can influence the time required to establish equilibrium 
conditions. Fine particles have more surface area and less 
internal volume for ions to diffuse, and so less time 
might be required to reach equilibrium. 
 
Figure 1: Molecular structure of Tramadol 
hydrochloride  
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ABSTRACT:  
Complexes of ion-exchange resins and Tramadol hydrochloride (TmH), a model drug, were prepared using a batch method 
with different functional groups, ion-exchange capacity, degree of cross linking, and resin particle size. Drug loading 
efficiency, release profiles, and scanning electron micrographs were also investigated. Most of the functional groups of resins 
were loaded with TmH after the completion of a double batch method and it was recommended for drug loading into the ion-
exchange resin. Using a batch method, drug loading could be monitored by simply measuring changes in the pH of the reaction 
medium since as complex formation reached completion, the pH returned to the initial pH of the eluent due to the limited 
amount of functional groups available for the exchange. TmH could be loaded up to the ratio of 1 (drug): 1 (resin), depending 
on the physicochemical properties of the resin. As the cross linking ratio and particle size increased, the drug loading and 
release rate decreased due to the reduced effective diffusion coefficient and surface area.  
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The ion-exchange resins to test in this study are cross 
linked gel type resins and their release kinetics is 
controlled mainly by drug diffusion through the gel. It 
has been reported that the kinetics of drug release from 
drug/resin complexes are dependent upon the amine 
moieties of the drugs used, such as NH2, –NH–, –N–, 
and –N+–; and the order of decreasing complex strength 
among the amine drugs follows: –N– >–NH–>NH2 
9. 
In this experiment, Tramadol hydrochloride was selected 
as a model drug and batch method was investigated to 
prepare drug/resin complexes to find the best preparation 
method for the complex preparation. Ion-exchange resins 
with different particle sizes, various degrees of cross 
linking, and different functional groups were also 
examined to optimize drug/resin complexes. Drug 
release kinetics of the resin complexes was evaluated 
using Boyd model to get information on the rate limiting 
step. 
MATERIALS AND METHODS 
Materials 
Tramadol hydrochloride, a model drug, was obtained 
from the IPCA laboratories Ltd. Mumbai Fig. 1 shows 
the molecular structure of Tramadol hydrochloride 
(TmH). Ion-exchange resins (Indion 224, Indion 244 
Indion 254 Indion 284 Indion 224 polystyrene sulfonate 
was purchased from the ION EXCHANGE Pvt. Ltd. 
Mumbai. 
Ion exchange resins are a cation-exchange resin with a 
cation exchange capacity of 4.3mequiv./g and a particle 
size mostly less than 1.3mm. All the resins were purified 
by rinsing three times with distilled water, one times 
with methanol, one time with benzene and then two 
times with distilled water again. Each treatment takes at 
least 6 h by a batch process. After filtration, the resin was 
dried in an oven. 
Analysis of Tramadol Hydrochloride  
Determination of Melting Point:-  
Melting point was determined by small amount of 
Tramadol hydrochloride in capillary tube closed at one 
end. The capillary tube was placed in an electrically 
operated digital melting point apparatus and the 
temperature at which the drug melts was recorded. This 
was performed thrice and average value was noted. DSC 
was used to determine the melting point of the Tramadol 
hydrochloride sample. The DSC analysis was carried out 
with Shimadzu DSC 60 thermal analyzer at the heating 
flow rate of 50 C /minute between the ranges 50-3000 C 
under static air using aluminium pans. 
Solubility:- 
The solubility of Tramadol hydrochloride was 
determined in different solvents like distilled water.0.1 N 
HCl, ethanol & various pH solutions. An excess quantity 
of the drug was added in 10 ml of each solvent in screw 
capped glass test tubes and shaken or 12 hours at room 
temperature. The solution was filtered, diluted and the 
solubility was determined by spectrophotometry. 
Partition coefficient:  
The partition coefficient study was performed using n-
octanol as oil phase and distilled water as aqueous phase. 
The two phases were mixed in an equal quantity and 
were saturated with each other on a mechanical water 
bath shaker at 320 C for 24 hrs. The saturated phase was 
separated. Each volume (10 ml each) of two phases was 
taken in a separating funnel and, this mixture 100 mg of 
weighed amount of drug was added. The separating tube 
was shaken for 24 hrs. to complete partitioning. The two 
phases were separated by separating funnel. And they 
were analyzed for respective drug contents. The partition 
coefficient of drug Ko/w was calculated using following 
formula. 
 Ko/w =
concentration  in octanol
concentration  in distilled water
 
Preliminary Evaluation of Resins 
Evaluation of physical properties  
The size of cationic Ion Exchange Resins was 
determined by microscopic method. Water absorption 
was obtained by keeping 500 mg of resin in contact with 
1 ml of water in a petridish. The time required for 
complete water absorption was recorded. 
Effect of resin activation:- 
To study the effect of method of resin activation on the 
complexation of drug with using the resins were 
activated by different methods. Resin 200 mg placed on 
a whatmann filter paper in a funnel, washed with 
deionized water and subsequently with 1N HCl 100 ml. 
The resin was rewashed with water until neutral pH was 
reached. Similarly, alkali activation of resin was 
performed by placing the resin in 1N NaOH solution. 
Finally resins were also activated with combined 
treatment of 1N HCl and 1N NaOH solutions.  
Preparation of Tramadol HCl-Loaded Resinate 
Beads 
The different types of resins were purified by rinsing two 
times with distilled water, one times with methanol, one 
time with benzene and then two times with distilled 
water again. Each treatment takes at least 6 h by a batch 
process.  After filtration, the resin was dried in an oven at 
40 ◦C for 24 h10. The TmH–resinate beads were prepared 
by a batch process, using the method described by Jeong 
and Park (2008). The previously purified resin particles 
(0.95 g dry weight) were dispersed in a 1.0 % (w/v) drug 
solution (100 ml) under magnetic stirring at room 
temperature for 5h (single batch).. In order to investigate 
how quickly equilibrium could be reached, 0.1mL of 
supernatant was collected at predetermined intervals 
during complex formation at room temperature, diluted 
with water, and then the drug amount was quantified 
spectrophotometrically at λmax 271 nm. The drug–
resinate beads were separated from the supernatant by 
filtration, washed with deionized water to remove any 
uncomplexed drug, and then dried in an oven at 40 ◦C for 
24 h 10. 
Evaluation of Drug Resin Beads 
Differential Scanning Calorimetry (DSC) of 
Tramadol HCl Resinate Beads 
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DSC was used to determine the melting point and to 
determine the molecular properties of Drug resin 
complex of the sample. The DSC analysis was carried 
out with Shimadzu DSC 60 thermal analyzer at the 
heating flow rate of 50 C /minute between the ranges 50-
3000 C under static air using aluminum pans. 
FT- IR of Tramadol HCl Resinate Beads 
The FT-IR analysis of the Drug and Dug resin complex 
sample were carried out for qualitative compound 
identification and compatibility between Tramadol 
hydrochloride and the selected resins .The pure drug and 
drug with resins were scanned separately. Potassium 
bromide was mixed with drug and resins in 9:1 ratio and 
the spectra was taken over a wavelength of 4000 cm-1 -
400 cm-1 . FT-IR spectrum of Tramadol hydrochloride 
was compared with FT-IR spectra with resins. 
Study of the effect of resin properties on in vitro 
release of Tramadol HCl from drug resinate beads  
Drug release from different drug–resinate beads 
(Indion224, Indion244, Indion 254, Indion 284) was 
conducted according to USP 24 dissolution apparatus II 
(paddle method). The dissolution media were 900 ml 
distilled water and maintained at 37±1 ◦C. Rotation 
speed was 50±1 rpm. An accurate weight of the Drug 
resin complex, equivalent to 100 mg of Tramadol 
hydrochloride was added in dissolution medium while 
the solution was agitated using the paddle. A 1 ml of 
sample was collected and replaced with fresh medium at 
appropriate interval. An absorbance of collected sample 
was measured by UV spectrophotometer at 271 nm. 
Scanning electron microscopy (SEM) 
Morphological characterization of the microspheres was 
carried using scanning electron microscopy (SEM‐S‐3 
700N, SHIMADZU). For SEM the double‐sided sticking 
tape, and coated with gold film (thickness 200nm) under 
the reduced pressure (0.001torr). 
RESULTS AND DISCUSSION 
Determination of Melting Point:-  
Melting point of Tramadol hydrochloride was 
determined by a capillary tube method. The capillary 
tube was placed in an electrically operated digital 
melting point apparatus and the temperature at which the 
drug melts was recorded. This was performed thrice and 
average value was found to be 183.0±0.6. This result was 
in conformation to the standard text.  The DSC studies 
also revealed that melting point at 184.0.  
Solubility:- 
The solubility of Tramadol hydrochloride was 
determined in different solvents.  The solution was 
filtered, diluted and the solubility was determined by 
spectrophotometrically and the observation is shown in 
Table: 2, Table 4. 
 Partition Coefficient:-   
The partition coefficient was determined by the shake 
flask or tube method and measuring the distribution of 
the solute is by UV Spectroscopy. 
Ko/w =
concentration  in octanol
concentration  in distilled water
 
Ko/w= 1.35 in distilled water 
FT-IR Studies   
As described in the methodology section the FT-IR 
studies were carried out for pure drug and along with ion 
exchange resins. They are summarized as follows.  The  
FT-IR spectra of Tramadol hydrochloride (fig-1) 
exhibited peaks at 2929.34cm-1 (C-H aromatic 
stretching), 2674.78 cm-1 (C-H  aliphatic stretching), 
3344.93 cm-1 (N-H amide bending), 1289.40 cm-1  (C-N 
bending) , 1606.41 cm-1 (C=C group), 1202.90(C-O 
group).Similarly FT-IR spectra of Tramadol 
hydrochloride in combination with ion exchange resins 
showed in figure 2 to 5. The FT IR spectra of solid drug: 
resin complex of Tramadol hydrochloride with different 
ion exchange resins indicated that the NH2 group of drug 
interacts with SO3H group of different resins (Indion 
224, Indion244, Indion254, and Indion284). This is 
confirmed by spectral analysis. Significant reduction in 
the intensity of distinctive peaks of drug demonstrates 
the formation of complex between drug and the resin 
molecule. The peaks are given in the Table 1 can be 
considered as characteristic peaks of the Tramadol 
hydrochloride. This indicates that there is interaction 
between Tramadol hydrochloride and different resins and 
the drug was complexed with the resins. 
 
Table 1 Data obtained for FT-IR spectra of Tramadol HCl along with ion exchange resins 
Drug =Tramadol hydrochloride 
 
 
Ingredients Principal Peaks(cm-1) 
Functional 
Groups 
C-H 
Str(aromatic) 
C-H 
Str(aliphatic) 
N-H C-N C=C C-O 
Pure Drug 2929.34 2674.78 3344.93 1289.40 1606.41 1202.90 
Drug+indion224 2943.73 2682.50 3300.57 1256.40 1597.73 1198.80 
Drug+Indion244 2928.38 2674.78 3321.89 1241.93 1677.77 1175.40 
Drug+Indion254 2929.38 2674.78 3305.39 1243.86 1578.45 1046.19 
Durg+Indion284 2929.34 2671.89 3303.46 1289.18 1606.41 1051.98 
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The FTIR and solubility studies suggests  that TmH 
exists in the  protonated drug ion which  can displace the 
hydrogen counter  ion  (H+)  at the sulfonic  acid 
functional groups on the IER  preparation.  
Re–SO3−H
+ + BH+ → Re–SO3−BH
+ + H+ 
Differential Scanning Calorimetry (DSC) Study
 
DSC studies for pure drug, selected ion exchange resin 
and drug resinate beads were carried out. The 
thermogram of pure drug, ion exchange resin (Indion 
244) and drug resinate beads (Tramadol +Indion 244) is 
shown in the figures 6, 7and 8 respectively. Thermogram 
of pure drug, presenting in the figure 6 indicate that 
melting of the drug is at 184.790C.  In the figure 7 
indicates that the melting of the ion exchange resin 
(Indion 244) without drug has taken place at 168.790C. 
The thermogram of DRC, presented in figure 8 indicates 
that the melting of DRC (Tramadol +Indion 244) has 
taken place at 175.880C. It could because the resins have 
undergone melt at 168.790C. Before the resin completely 
melts, the drug might have started melting giving the 
broad peak that is 175.88
0
C.Further no more peaks were 
found in the figure 8. 
Preliminary Evaluation of Resins 
Evaluation of physical properties  
The size of cationic Ion Exchange Resins was 
determined by microscopic method. The size of resins 
particles of Indion 284, Indion 254 was found to be ≤150 
µm, which is in confirmation with that reported in the 
literature. Similarly the particle size of Indion 224 and 
Indion 244 were also found to be within the range 
reported in the literature.  The water uptake time of 
resins were found to be 43 to 67 seconds. The result 
shows that Ion Exchange Resins beings highly porous 
and even though insoluble in water are capable of 
hydration. The results were shown in Table 3. The 
swelling time of selected IER was found to be directly 
proportionally to the particle size of the resins. 
Effect of resin activation  
To study the effect of pH of the activation medium of 
IER on percentage drug loading (single batch method), 
the resin were activated in the different pH environment 
(the result are reported in table 5and figure 9). It was 
found that highest drug loading was obtained in the resin 
treated with acid alkali combination. This study also 
revealed that highest complexation was achieved with 
Indion 244 IER.       
Effect of resin particle size and degree of cross linking 
on the loading equilibrium time: 
Resins of various particle sizes and degrees of cross 
linking were used to investigate their effect on the 
equilibrium time. The weight ratio between the drug and 
resin was 1:1 for the loading. Fig. 10 shows the 
equilibrium profiles of drug loading onto different ion 
exchange resins. The loading of Tramadol hydrochloride 
in all the selected resins was more than 50%. The 
equilibrium time was approximately 120 min for Indion 
244 and Indion 224. However it was 60 min in case of 
Indion 254 and Indion 284.  The difference in 
equilibrium time obtained was due to the influence of the 
degree of cross-linking and the particle size of the resins. 
The particle size distribution of Indion224 is 0.2-1.2 mm, 
Indion 284 is≤ 0.15 mm Indion 254 is≤0.15 mm, and 
Indion 244 is 0.2-1.2 mm. Coarse particles have smaller 
surface area than fine particles and greater internal 
volume for ions to diffuse, so more time can be required 
to establish equilibrium. Resins with lower degree of 
cross linking reached equilibrium faster than resins with 
higher one having the same particle size. It is obvious 
that the amount of TmH remaining is greater in case of 
Indion 244 than Indion 284. When an ion-exchange resin 
is highly cross linked, the diffusion of various ions can 
be impeded, and this will slightly increase the time 
required to reach equilibrium and reduce the amount of 
drug loaded onto IER. 
Effect of resin particle size and degree of cross linking 
on the in vitro release of TmH from drug resinate 
beads:   
Fine particles have more surface area than coarse 
particles and less internal volume for ions to diffuse, so 
less time can be required to establish equilibrium. 
Similarly, desorption of bound drug from the complex 
will be faster in fine particles. Fig. 11  shows the release 
profiles of TmH from drug–resinate beads with  different 
particle size resins (Indion 224 is 0.2-1.2mm, Indion 284 
is ≤0.15 mm Indion 254 is≤0.15 mm, and Indion 244 is 
0.2-1.2.) It is obvious that the higher degree of cross 
linking of resins, the slower the release of the drug. 
Statistical analysis revealed that TmH–resinate with 
Indion 284 showed significantly faster drug release 
(34.24, 73.96, and 90.33%), compared to TmH–resinate 
with Indion 244 resinate (30.63, 59.51, and 77.66%) after 
2, 4, and 6 h, respectively This may be attributed to the 
swelling properties of the resin. The higher degree of 
cross linking resins swell less than the lower ones, and 
hence is more resistant to diffusion of drug molecule 
throughout the resin particle. Results also showed that 
decreasing the particle size results in a faster drug 
release. This is attributed to the greater surface area 
exposed to the dissolution medium, which facilitates the 
exchange process. 
Based on the above results, we decided to prepare drug 
resin microcapsules of TmH that approach the zero order 
kinetics for once daily administration and prevent brust 
release. The drug resin complex with Indion 244 was 
selected as highest drug binding of 69.82% and the 
desired slow release of drug was observed with  resinate 
of drug with Indion 244 was selected to be 
microencapsulation in order to achieve the targeted 
controlled release effect. 
The In vitro release kinetics as presented in Table 6  
suggests that drug release from resinates of Indion 224, 
Indion 254, Indion 244 follows zero order kinetics, 
however  the release of the drug from resinate of  Indion 
284 follows first order kinetics. These conclusions are 
based on Co-relation coefficient of linear relationship.  
CONCLUSIONS 
TmH loaded ion-exchange resins were prepared using a 
batch process with different functional groups, ion-
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exchange capacity, degree of cross linking, and resin 
particle size. Most of the functional groups of the resins 
were loaded with TmH after the completion of a single 
batch method and it was recommended for the drug 
loading into the ion-exchange resin. When a batch 
method was applied, simply measuring changes in the 
pH of the reaction medium could monitor drug loading, 
because as complex formation reached completion, the 
pH returned to the initial pH of the eluent. TmH could be 
loaded up to the ratio of 2 (drug): 1 (resin), depending on 
the physicochemical properties of the resin. As the cross 
linking ratio and particle size increased, the drug loading 
and release rate decreased due to the reduced effective 
diffusion coefficient and surface area. Fine particles 
required less time to establish equilibrium because of 
more surface area and less internal volume for ions to 
diffuse. Similarly, desorption of bound drug from the 
complex was faster in fine particles. Moreover, when an 
ion exchange resin is highly cross linked, the diffusion of 
various ions was impeded, and this increased the time to 
equilibrium and reduced the amount of loaded drug.  
 
 
Figure 1: FT- IR spectra of Tramadol hydrochloride drug 
 
Figure 2:  FT- IR spectra of Tramadol hydrochloride drug+Indion224 
 
 
Figure 3: FT-IR spectra of Tramadol hydrochloride drug+Indion244     
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                             Figure 4: FT-IR spectra of Tramadol hydrochloride drug+Indion 254 
 
Figure 5: FT IR spectra of Tramadol hydrochloride drug+Indion 284 
 
Figure 6:  DSC thermogram of Tramadol hydrochloride 
 
Figure 7:   DSC thermogram of Indion 244 
 
 
Figure 8: DSC thermogram of Drug resin complex ( Drug+ Indion 244 ) 
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Table 2: Solubility of Tramadol hydrochloride in different solvents 
          
 
 
 
 
Table 3: Evaluation of Physical Properties of Cationic Ion Exchange Resins 
 
 
 
 
 
Table 4: Solubility profile of Tramadol hydrochloride in pH solutions 
 
 
 
 
 
 
 
 
 
Table 5: Effect of resin activation on % drug complexation by single batch method 
 
 
 
Figure 9: Effect of resin activation on % drug complexation 
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Indion 224
Indion 244
Indion 254
Indion 284
S.No. Solvents Solubility(mg/ml) 
1 Water 64.76 
2 0.1 N HCl 64.58 
3 Methanol 68.00 
Resins Particle Size 
(mm) 
Swelling time 
(seconds) 
Indion 224 0.2-1.2 61±6 
Indion 284 ≤0.15 45±3 
Indion 254 ≤0.15 43±7 
Indion 244 0.3-1.2 67±5 
S.No Solvents Solubility(mg/ml) 
1 pH 1.2 64.58 
2 pH 2.2 66.14 
3 pH 4.2 68.00 
4 pH 6.0 61.96 
5 pH 6.4 63.78 
6 pH 6.8 64.14 
7 pH 7.4 64.90 
Resins Effect of resin activation on %  drug complexation 
Inactivated  Acid  Base  Acid +Base 
Indion 224   53.86   51.08     51.56          51.84 
Indion 244   56.64   55.30     69.52          69.82 
Indion 254   50.30   50.10     51.56          51.60 
Indion 284  51.12   61.10     59.66          61.84 
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Figure 10: Equilibrium profile of drug loading onto 
different ion exchange resins 
 
Figure 11: Effect of resin particle size and degree of 
cross linking on the in vitro release of TmH from drug 
resinate beads.
 
Table 6: In Vitro Release Kinetics of Drug from different resinate 
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    Resins 
Zero order First order Higuchi  Korsemeyer peppas 
K0 R
2 
K1 R
2 
KH R
2 ‘n’ R2 
INDION 224 0.307 0.983 0.0445 0.981 3.540 0.973 0.697 0.996 
INDION 244 0.254 0.986 0.0452 0.971 3.165 0.955 0.927 0.981 
INDION 254 0.351 0.984 0.0433 0.959 4.118 0.973 0.740 0.969 
INDION 284 0.269 0.968 0.0446 0.984 3.455 0.979 0.961 0.969 
